LSBCF (LakeShore Biopharma Co) Gross Profit: $71.00 Mil (TTM As of Mar. 2025)


What is LakeShore Biopharma Co Gross Profit?

LakeShore Biopharma Co LSBCF Gross Profit is $71.00 Mil as of Mar. 2025.

LakeShore Biopharma Co's gross profit for the six months ended in Mar. 2025 was $27.58 Mil. LakeShore Biopharma Co's gross profit for the trailing twelve months (TTM) ended in Mar. 2025 was $71.00 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. LakeShore Biopharma Co's gross profit for the six months ended in Mar. 2025 was $27.58 Mil. LakeShore Biopharma Co's Revenue for the six months ended in Mar. 2025 was $33.52 Mil. Therefore, LakeShore Biopharma Co's Gross Margin % for the quarter that ended in Mar. 2025 was 82.27%.

LakeShore Biopharma Co had a gross margin of 82.27% for the quarter that ended in Mar. 2025 => Durable competitive advantage

LakeShore Biopharma Co  (OTCPK:LSBCF) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

LakeShore Biopharma Co had a gross margin of 82.27% for the quarter that ended in Mar. 2025 => Durable competitive advantage

LakeShore Biopharma Co Gross Profit Related Terms

LakeShore Biopharma Co Gross Profit Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Gross Profit Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Gross Profit
30.31 60.82 77.47 63.28 69.96

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Gross Profit Get a 7-Day Free Trial Premium Member Only 33.09 30.27 32.61 43.42 27.58

LSBCF vs ACUT, PPCB, ENSC: Gross Profit Comparison

For the Biotechnology subindustry, LakeShore Biopharma Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LakeShore Biopharma Co Gross Profit vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where LakeShore Biopharma Co's Gross Profit falls into.


LakeShore Biopharma Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

LakeShore Biopharma Co's Gross Profit for the fiscal year that ended in Mar. 2025 is calculated as

Gross Profit (A: Mar. 2025 )=Revenue - Cost of Goods Sold
=84.831 - 14.867
=69.96

LakeShore Biopharma Co's Gross Profit for the quarter that ended in Mar. 2025 is calculated as

Gross Profit (Q: Mar. 2025 )=Revenue - Cost of Goods Sold
=33.523 - 5.944
=27.58

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $71.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

LakeShore Biopharma Co's Gross Margin % for the quarter that ended in Mar. 2025 is calculated as

Gross Margin % (Q: Mar. 2025 )=Gross Profit (Q: Mar. 2025 ) / Revenue (Q: Mar. 2025 )
=(Revenue - Cost of Goods Sold) / Revenue
=27.58 / 33.523
=82.27 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Profit →
What does a Gross Profit of $71.00 Mil mean?
LakeShore Biopharma Co (LSBCF) has a Gross Profit of $71.00 Mil as of Mar. 2025. Gross Profit equals net sales less total cost of goods sold. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Gross Profit too high?
LakeShore Biopharma Co's current Gross Profit is $71.00 Mil.
How does LakeShore Biopharma Co's Gross Profit compare to ACUT and PPCB?
LakeShore Biopharma Co's Gross Profit of $71.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Biotechnology company?
A good Gross Profit depends on the Biotechnology industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Gross Profit is $71.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Gross Profit of $71.00 Mil. The current Gross Profit is $71.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Gross Profit is $71.00 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.